JNC :: Journal of Neurocritical Care

J Neurocrit Care

> Browse Articles > J Neurocrit Care

Management strategies for refractory status epilepticus

Jung-Won Shin

J Neurocrit Care. 2023;16(2):59-68. Published online December 19, 2023

doi: https://doi.org/10.18700/jnc.230037

Unexpected epileptogenic effect of lethal doses of pentobarbital: a case report

Amélie Giudicelli-Bailly, Chiara Della Badia, Marc Augsburger, Hervé Quintard, Raphaël Giraud, Pia De Stefano

J Neurocrit Care. 2023;16(1):46-50. Published online June 28, 2023

doi: https://doi.org/10.18700/jnc.230019

Cited By 1

Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus

Hyun-Sung Kim, Jiyoung Kim, Bo-Jin Hwang, Kyoung-Nam Woo, Min-Gyu Park, Kyung-Pil Park, Sung-Ho Ahn

J Neurocrit Care. 2020;13(1):65-68. Published online June 15, 2020

doi: https://doi.org/10.18700/jnc.190115

Nonconvulsive status epilepticus associated with leptomeningeal carcinomatosis and positive SOX1 antibodies

Jeong Yeon Kim, Ga Yeon Kim, Jin Heon Jeong, Sang Ho Kim

J Neurocrit Care. 2020;13(1):61-64. Published online June 26, 2020

doi: https://doi.org/10.18700/jnc.190105

Cited By 1

Cefepime-induced neurotoxicity

Se-Jin Lee

J Neurocrit Care. 2019;12(2):74-84. Published online December 24, 2019

doi: https://doi.org/10.18700/jnc.190109

Cited By 17

Status epilepticus due to cerebral air embolism after the Valsalva maneuver

Hyun Ji Lyou, Hye Jeong Lee, Grace Yoojin Lee, Won-Joo Kim

J Neurocrit Care. 2019;12(1):51-54. Published online June 19, 2019

doi: https://doi.org/10.18700/jnc.190075

Cited By 1

Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status Epilepticus

Tae-Won Yang, Jeong Won Jo, Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwon

J Neurocrit Care. 2018;11(2):137-142. Published online December 21, 2018

doi: https://doi.org/10.18700/jnc.180066

Crossed Cerebellar Diaschisis in Convulsive Status Epilepticus

Shin Yeop Kim, Jeong A Park, Ji Eun Kim

J Neurocrit Care. 2016;9(1):25-27. Published online June 30, 2016

doi: https://doi.org/10.18700/jnc.2016.9.1.25

Treatment of Status Epilepticus

Gha-Hyun Lee, Dae Soo Jung

J Neurocrit Care. 2016;9(1):1-6. Published online June 30, 2016

doi: https://doi.org/10.18700/jnc.2016.9.1.1

Progressive Posterior Encephalopathy Syndrome Related with Drug-refractory Hypertension in a Patient with Pheochromocytoma

Yu Jin Jung, Youngnam Kwon, Sung Hyuk Heo, Kyoung Jin Hwang, Dae-Il Chang

J Neurocrit Care. 2014;7(2):141-144. Published online December 30, 2014

doi: https://doi.org/10.18700/jnc.2014.7.2.141

Neurotoxicity by Cefepime: Case-Control Study

Joong Koo Kang, Soon Bae Kim

J Neurocrit Care. 2014;7(2):104-110. Published online December 30, 2014

doi: https://doi.org/10.18700/jnc.2014.7.2.104

Cited By 4

Interesting Cases of Status Epilepticus

Do-Hyeon Nam, MD and Jun-Young Lee, MD

J Neurocrit Care. 2012;5(1):21-24.

Patient Monitoring in NICU

Joong Koo Kang, MD, PhD

J Neurocrit Care. 2010;3(Suppl 2):122-125.

Seizures, EEG Monitoring in NICU

Hong Ki Song, MD

J Neurocrit Care. 2010;3(Suppl 2):118-121.

Continuous Seizures

Dae-Won Seo, MD, PhD

J Neurocrit Care. 2010;3(Suppl 1):19-22.

Nonconvulsive Status Epilepticus

Se-Jin Lee, MD, PhD

J Neurocrit Care. 2009;2(Suppl 2):94-102.

Status Epilepticus

Gyu Sik Kim, MD

J Neurocrit Care. 2008;1(Suppl 1):78-81.

Status Epilepticus Possibly Caused by Hair Dye Exposure in a Diabetic Man

Yong-Sik Jung, MD Seok-Beom Kwon, MD, Suk Yun Kang, MD, San Jung, MD and Sung-Hee Hwang, MD, PhD

J Neurocrit Care. 2008;1(2):168-170.

Status Epilepticus: Recent Updates

Se Jin Lee, MD, PhD

J Neurocrit Care. 2008;1(1):111-116.

A Case of Neuro-Behcet’s Disease Presenting with Recurrent Status Epilepticus

Young-Ho Koo, MD Seung-Hun Oh, MD, Won-Chan Kim, MD, Hyun Sook Kim, MD and Ok Joon Kim, MD, PhD

J Neurocrit Care. 2008;1(1):54-58.

1 |

Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116

The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.

First decision

15 Days

Publication after acceptance

40 Days

Submission to publication

79 Days

Acceptance rate

59 %

*Last 12 months